X4 PHARMACEUTICALS, INC Class of Warrant or Right, Outstanding
X4 PHARMACEUTICALS, INC (XFOR) had Class of Warrant or Right, Outstanding of 37.92 million shares as of 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-03-17
- 2025-12-31: Class of Warrant or Right, Outstanding 37.92M shares.
- 2025-06-30: Class of Warrant or Right, Outstanding 3.63M shares.
- 2025-03-31: Class of Warrant or Right, Outstanding 3.63M shares.
- 2024-12-31: Class of Warrant or Right, Outstanding 3.63M shares; Class of Warrant or Right, Outstanding as first filed 108.79M shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2025-12-31 | 37.92M shares 10-K · filed 2026-03-17 | |
| 2025-06-30 | 3.63M shares 10-Q · filed 2025-08-08 | |
| 2025-03-31 | 3.63M shares 10-Q · filed 2025-05-01 | |
| 2024-12-31 | 3.63M shares 10-K · filed 2026-03-17 | 108.79M shares 10-K · filed 2025-03-26 |
| 2024-09-30 | 108.79M shares 10-Q · filed 2024-11-13 | |
| 2024-06-30 | 108.79M shares 10-Q · filed 2024-08-08 | |
| 2024-03-31 | 112.66M shares 10-Q · filed 2024-05-07 | |
| 2023-12-31 | 3.76M shares 10-K · filed 2026-03-17 | 112.66M shares 10-K · filed 2024-03-21 |
| 2023-09-30 | 112.66M shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 112.66M shares 10-Q · filed 2023-08-10 | |
| 2023-03-31 | 111.87M shares 10-Q · filed 2023-05-04 | |
| 2022-12-31 | 3.73M shares 10-K · filed 2026-03-17 | 111.87M shares 10-K · filed 2023-03-21 |
| 2022-09-30 | 78.23M shares 10-Q · filed 2022-11-03 | |
| 2022-06-30 | 14.02M shares 10-Q · filed 2022-08-04 | |
| 2022-03-31 | 14.02M shares 10-Q · filed 2022-05-12 | |
| 2021-12-31 | 13.26M shares 10-K · filed 2025-03-26 | |
| 2021-09-30 | 11.25M shares 10-Q · filed 2021-11-04 | |
| 2021-06-30 | 11.27M shares 10-Q · filed 2021-08-03 | |
| 2021-03-31 | 12.33M shares 10-Q · filed 2021-05-06 | |
| 2020-12-31 | 13.35M shares 10-K · filed 2024-03-21 | |
| 2020-09-30 | 13.51M shares 10-Q · filed 2020-11-05 | |
| 2020-06-30 | 13.66M shares 10-Q · filed 2020-08-04 | |
| 2020-03-31 | 13.66M shares 10-Q · filed 2020-05-07 | |
| 2019-12-31 | 13.66M shares 10-K · filed 2021-03-19 | |
| 2019-09-30 | 6.49M shares 10-Q · filed 2020-11-05 | |
| 2019-06-30 | 6.49M shares 10-Q · filed 2020-08-04 | |
| 2019-03-31 | 494.05K shares 10-Q · filed 2020-05-07 | 494.05K shares 10-Q · filed 2019-05-15 |
| 2018-12-31 | 5.15M shares 10-K · filed 2021-03-19 | |
| 2018-03-31 | 10.41K shares 10-Q · filed 2018-05-10 | |
| 2017-12-31 | 10.41K shares 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |